Track the 페니트리움바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 페니트리움바이오 has published 50 insider filings. Market capitalisation: €285.9bn. The latest transaction was filed on 4 September 2026 (Purchase). Among the most active insiders: 모비스. The full history is openly available.
43
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
13 ops.
Sell Volume
Fundamental score
Ranked 27,873 of 29,064 companies
14.5
score / 100
Value
26
Quality
3
FCF yld-1.8%
Earn yld-5.2%
EV/EBITDA·
ROE-89%
Gross mgn0.4%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
페니트리움바이오 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biopharmaceutical solutions.